Automation of enzyme immunoassay for Lp-PLA2 using DSX™ system

被引：0
|
作者：
Faix, J.
Pangilinan, P.
Johal, S.
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
[2] diaDexus Inc, San Francisco, CA USA
来源：
CLINICAL CHEMISTRY | 2007年 / 53卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
A-10
引用
收藏
页码：A4 / A4
页数：1
相关论文
共 50 条
  • [1] Role of Lp-PLA2 in atherosclerosis
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (01) : 13 - 13
  • [2] Plasma Lp-PLA2 mass and apoB-lipoproteins that carry Lp-PLA2 decrease after sodium
    Constantinides, Alexander
    Kerstens, Michiel N.
    Dikkeschei, Bert D.
    van Pelt, L. Joost
    Tellis, Constantinos C.
    Tselepis, Alexandros D.
    Dullaart, Robin P. F.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (11) : 1235 - 1243
  • [3] Lp-PLA2 as a Marker of Cardiovascular Diseases
    Sabha Bhatti
    Abdul Hakeem
    Mehmet Cilingiroglu
    Current Atherosclerosis Reports, 2010, 12 : 140 - 144
  • [4] Lp-PLA2 linked to heart failure
    不详
    FUTURE CARDIOLOGY, 2006, 2 (06) : 624 - 624
  • [5] Lp-PLA2 as a Marker of Cardiovascular Diseases
    Bhatti, Sabha
    Hakeem, Abdul
    Cilingiroglu, Mehmet
    CURRENT ATHEROSCLEROSIS REPORTS, 2010, 12 (02) : 140 - 144
  • [6] Lp-PLA2:: A new kid on the block
    Zalewski, Andrew
    Nelson, Jeanenne J.
    Hegg, Lisa
    Macphee, Colin
    CLINICAL CHEMISTRY, 2006, 52 (09) : 1645 - 1650
  • [7] The Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Gene is Associated With Plasma Lp-PLA2 Mass and Activity
    Holkanson, John E.
    Kinney, Gregory L.
    Snell-Bergeon, Janet K.
    Rewers, Marian
    CIRCULATION, 2009, 120 (18) : S606 - S606
  • [8] Lp-PLA2 Inhibition-The Atherosclerosis Panacea?
    Karakas, Mahir
    Koenig, Wolfgang
    PHARMACEUTICALS, 2010, 3 (05): : 1360 - 1373
  • [9] Lp-PLA2: A New Target for Statin Therapy
    Braun, Lynne T.
    Davidson, Michael H.
    CURRENT ATHEROSCLEROSIS REPORTS, 2010, 12 (01) : 29 - 33
  • [10] Novel enzymatic method for assaying Lp-PLA2
    Yamaura, S.
    Sakasegawa, S.
    Ueda, S.
    Kayamori, Y.
    Sugimori, D.
    Karasawa, K.
    CLINICA CHIMICA ACTA, 2019, 493 : S190 - S191
12345